Ruxolitinib hydrochloride is the hydrochloride salt form of a compound used as an active pharmaceutical ingredient. It features a complex organic structure containing aromatic rings and a nitrile group, and is supplied as a research-grade or manufacturing-grade chemical.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 1912373-07-9
Ruxolitinib
pharmaceutical raw material
(betaR)-beta-Cyclopentyl-4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazole-1-propanenitrile maleate
research compound
Ruxolitinib phosphate
pharmaceutical raw material
Branebrutinib
pharmaceutical raw material
Duvoglustat
pharmaceutical raw material
Α-ochratoxin
pharmaceutical raw material
(17S)-Volicitin
pharmaceutical raw material
Deuruxolitinib phosphate
pharmaceutical raw material
(3R)-3-cyclopentyl-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)pyrazol-1-yl]propanenitrile;hydrochloride
ZYSGMFZLLDZEBY-XFULWGLBSA-N
C1CCC(C1)[C@@H](CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3.Cl